Symposium at ALS/MND

INNOVATION LANDSCAPE IN ALS/MND:

DESIGNING TOMORROW’S CLINICAL TRIALS TODAY
INCLUSION AND EXCLUSION CRITERIA: A LIVE DEBATE

SATURDAY, DECEMBER 8, 2018

6:45 am — 8:15 am

Breakfast will be served.
Argyll Suite, Crowne Plaza, Glasgow, UK

PROGRAM OBJECTIVES

Provide overview of the current status of patient inclusion and exclusion criteria in ALS clinical trials
Discuss and debate broad versus narrow inclusion and exclusion criteria used in ALS clinical trials
Highlight approaches to patient inclusion and exclusion criteria that can improve detection of significant and meaningful change in ALS clinical trials

FACULTY

Prof. Dame Pamela Shaw, DBE, MBBS, MD, FRCP, FMedSci, FAAN, FANA, FAAAS

Program Chair

Vice President and Head of the Faculty of Medicine and Dentistry, University of Sheffield

Professor of Neurology, University of Sheffield

Director, Sheffield Institute for Translational Neuroscience (SITraN)

Director, NIHR Biomedical Research Centre Translational Neuroscience for Chronic Neurological Disorders

Director, Sheffield Care and Research Centre for Motor Neuron Disorders

Consultant Neurologist, Sheffield Teaching Hospitals NHS Foundation Trust

Angela Genge, MD, FRCP(C), MBA

Director, Montreal Neurological Institute’s ALS Clinical Research Program